Home › Mutual Funds › Tata Mutual Fund › Tata India Pharma & Healthcare Fund Direct Payout of Inc Dist cum Cap Wdrl
Latest NAV & returns of TATA ASSET MANAGEMENT LTD.

Tata India Pharma & Healthcare Fund Direct Payout of Inc Dist cum Cap Wdrl

Add To Compare

previously known as Tata India Pharma & Healthcare Dir DP until

33.406 (-1.016%)
NAV on March 27, 2026
Category Equity:
Sector - Healthcare
Investment StyleBox
Mid Growth
Total Assets 1,301 cr
Turnover Ratio 11.18%
Expense Ratio 0.69%
Exit Load 0.25%if redeemed within
30 Days0.00%if redeemed after 30 Days
Returns
  • 1M: -5.20%
  • 1Y: 1.24%
  • 3M: -5.71%
  • 3Y: 23.69%
  • 6M: -4.47%
  • 5Y: 16.37%
Min Investment 5,000
Buy Now Start SIP
ADDITIONAL INFO
Fund Manager Rajat Srivastava (Since over 1 year)
ISIN INF277K011B8
Fund Family Tata
P/E Ratio 41.15
P/B Ratio 6.83
Launch Date December 28, 2015
Benchmark Nifty Pharma TR INR
ASSET ALLOCATION
EQUITY DISTRIBUTION
RISK MEASURES (3 yrs)
vs Nifty Pharma TR INR

Alpha 1.00
Beta 0.95
R-Squared 94.78
Info Ratio 0.04
Tracking Err 3.78
Sortino 2.035
Sharpe 1.129
Std Dev 16.162
Risk -
SECTOR WEIGHTINGS (%)
Financial 0.0%
Industrial 0.0%
Technology 0.0%
Basic Materials 3.42%
Consumer Cyclical 0.0%
Utilities Services 0.0%
Healthcare Services 96.58%
Energy Services 0.00%
Communication Services 0.00%
Consumer Defensive 0.00%
Real Estate 0.00%
INVESTMENT OBJECTIVE

The investment objective of the scheme is to seek long term capital appreciation by investing atleast 80% of its net assets in equity/equity related instruments of the companies in the pharma & healthcare sectors in India.

This fund may declare and pay out a dividend to you on a periodic basis, but only when it has the profits to do so.

View Factsheet
-
Best Sector Healthcare Funds
NAME LATEST
NAV		 RETURNS
1y     		FUND
ASSETS		 Expense
RATIO		 RISK
Mirae
Mirae Asset Healthcare Fund Direct Growth
43.153 6.85% 2,844 cr 0.47% -
Uti
UTI Healthcare Fund-Growth Option- Direct
312.389 3.98% 1,107 cr 1.29% -
Sbi
SBI Healthcare Opportunities Fund Direct Growth
485.843 3.64% 4,077 cr 0.91% -
Icici
ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund Direct Growth
40.320 3.12% 6,801 cr 1.04% -


Other plans of Tata India Pharma & Healthcare


Other Equity funds by Tata

Data Partner
Click here to visit AMC website and
read all scheme related documents Tata Fund